Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 4:31 AM
Ignite Modification Date: 2025-12-25 @ 4:31 AM
NCT ID: NCT05743218
Eligibility Criteria: Inclusion Criteria: \- The inclusion criteria are as follows: 1. patients with the detection indicators within 3 months before enrollment met the diagnostic criteria of DOR. 2. patients aged between 18 and 40 years old. 3. patients who have received no other treatment in the 2 months before enrollment. (4) patients who voluntarily participate in this study and can actively cooperate with the study process. (5) patients who have signed an informed consent form. Patients who meet all five criteria will be eligible for this study. Exclusion Criteria: * (1) Patients with polycystic ovarian syndrome, hyperprolactinemia, pituitary or hypothalamic amenorrhea, thyroid dysfunction, congenital malformations, and organic lesions in the reproductive organs. (2) Patients with a history of local ovarian surgery, such as oophorectomy and ovarian tumor surgery. (3) Patients with a history of chemotherapy or pelvic radiotherapy and a history of therapy with immunosuppressive agents. (4) Patients with comorbidities in the cardiovascular system, liver, kidney, hematopoietic system, nervous and mental system, diabetes, hypertension, and other diseases. (5) Patients being administered estrogen, progesterone, or dehydroepiandrosterone (DHEA) within 2 months before enrollment. (6) Patients who cannot tolerate blood or ultrasound testing. (vii) Patients who are also participating in other clinical trials. (7) Patients who refuse to sign the informed consent form. Patients who meet any of the above criteria will be excluded.
Healthy Volunteers: False
Sex: FEMALE
Minimum Age: 18 Years
Maximum Age: 40 Years
Study: NCT05743218
Study Brief:
Protocol Section: NCT05743218